Cost analysis of adverse events associated with non-small cell lung cancer management in France

BACKGROUND: Adverse events (AEs) related to medical treatments in non-small cell lung cancer (NSCLC) are frequent and need an appropriate costing in health economic models. Nevertheless, data on costs associated with AEs in NSCLC are scarce, particularly since the development of immunotherapy with s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clinicoecon Outcomes Res
Autors principals: Chouaid, Christos, Loirat, Delphine, Clay, Emilie, Millier, Aurélie, Godard, Chloé, Fannan, Amira, Lévy-Bachelot, Laurie, Angevin, Eric
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5538537/
https://ncbi.nlm.nih.gov/pubmed/28794648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S138963
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars